Assoc. Prof. Kayhan BOLELLI, Ph.D.

URL : http://kisisel.ankara.edu.tr/pharmacy.ankara.edu.tr/bolelli/
Email : bolelli@ankara.edu.tr
Tel : +90 (312) 203 30 86

Biografía Corta

Kayhan Bolelli (nació el 11 de Febrero de 1982 en Çanakkale – Turquía) es un farmacéutico turco y Doctorado en Filosofía (Ph.D.) miembro de la facultad en la Universidad de Ankara, Facultad de Farmacia, Departamento de Química Farmacéutica. Se graduó de la Universidad de Ankara, Facultad de Farmacia, con licenciatura en 2004; del Departamento de Química Farmacéutica de la misma facultad, con maestría en ciencias en 2007; desde el mismo departamento, con doctorado en filosofía en 2016. Está trabajando en el diseño de fármacos asistidos por computadora, síntesis orgánica, relaciones estructura-actividad y actividades biológicas de compuestos heterocíclicos como las actividades antimicrobianas y antitumorales desde 2004.

Educational and Administrative Background

2000-2004: B.Sc. at Ankara University Faculty of Pharmacy
2004-2007: M.Sc. at Ankara University Faculty of Pharmacy Department of Pharmaceutical Chemistry (Supervisor: Prof. Ismail Yalcin, Ph.D.)
2007-2016: Ph.D. Student at Ankara University Faculty of Pharmacy Department of Pharmaceutical Chemistry (Supervisor: Prof. Ismail Yalcin, Ph.D.)

Language Background

  • Turkish (Native Language)
  •  English (Fluent) 
  •  Spanish (Beginner Level)

Research Interests

  • Pharmaceutical Chemistry
  • Pharmaceutical Organic Synthesis
  • Drug Design
  • QSAR
  • Molecular Modeling
  • Pharmacophore Analysis
  • Docking

Awards Received

  • Fatma Zilifdar, Egemen Foto, Ömür Bostanci, Sibel Sari, Kayhan Bolelli, Ismail Yalcin, Nuran Diril. Mutagenic Activity of 4 Newly Synthesized Heterocyclic Compounds, 1st International Congress & Workshop of Forensic Toxicology (1st ForeTox 2014), Ankara, Turkey, P14: p71, 29-30 November 2014. (ULUSLARARASI ADLİ TOKSIKOLOJİ KONGRE VE ÇALIŞTAYI - Poster 2.’lik ödülü)

Work Experience

  • Internship in Evcim Pharmacy in 2001-2002
  • Medical Manager Asistant in Medical Division in PFIZER Inc. in 2003
  • Medical Pollster in ProCon Gfk Research Services in 2004
  • Selling Department Asistant in AVENTIS-PASTEUR Vaccine Trade Company in 2004
  • Mandate Manager in Norman Cosmetics in 2005
  • Vice-Head of Quality Control and R&D Laboratory in Commandership of Drug Factory (Republic of Turkey Ministry of National Defense) in 2008
  • Research Assistant in Department of Pharmaceutical Chemistry (Ankara University, Faculty of Pharmacy) since 2005

Editorial Board Memberships

  • Organic and Medicinal Chemistry International Journal (OMCIJ), Juniper Publishers, Thousand Oaks, CA, USA. (ISSN: 2474-7610) (09.06.2017) - Associate Editor
  • Journal of Faculty of Pharmacy of Ankara University, Ankara, TR, Turkey. (21.03.2017) – Associate Editor
  • Electronical Bulletin of Faculty of Pharmacy of Ankara University, Ankara, TR, Turkey. (09.03.2015) – Editor

 

  • Biomedical Journal of Scientific & Technical Research (BJSTR), New York, NY, USA. (Editorial Committee) (02.06.2017)
  • NorCalOA Journal of Pharmaceutical Sciences and Experimental Pharmacology, Santa Clara, CA, USA. (01.06.2017)
  • DOZ Journal, Chamber of Pharmacist of Ankara, Ankara, TR, Turkey. (05.04.2017)
  • HSOA Journal of Pharmaceutics, Drug Delivery & Safety, VA, USA. (04.10.2016)

Symposium and Meeting Organizations

  • Member of Local Organizing Committee in the "2st International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, October 25-28, 2013.
  • Member of Social and Registration Committee in the "European Association of Faculties of Pharmacy 2013 Annual Conference (EAFP 2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, May 16-18, 2013.
  • Member of Social and Registration Committee in the “10th International Symposium on Pharmaceutical Sciences (ISOPS-10)”, Ankara University, Faculty of Pharmacy, Ankara, Turkey, June 26-29, 2012.
  • Member of Technical Committee in the “1st International Conference on New Trends in Chemometrics and Applications (NTCA-2011), Side, Antalya, Turkey, October 08-11, 2011.
  • Member of Registration Committee in the “XII. National Spectroscopy Congress with International Participation", Side, Antalya, Turkey, May 18-22, 2011.
  • Member of Organizing Committee in the “9th International Symposium on Pharmaceutical Sciences (ISOPS-9)”, Ankara University, Faculty of Pharmacy, Ankara, Turkey, June 23-26, 2009.

Workshops

  • Tübitak 2237 Proje Eğitimi Etkinliklerini Destekleme Programı, Sağlık Bilimleri Alanında Proje Hazırlama ve Yürütme Eğitimi: Ankara 2015, 20-22 Mart 2015, Ankara Üniversitesi Tıp Fakültesi, Ankara, Türkiye.
  • Advances in Small and Large Molecule Characterization in the Pharmaceutical Industry, Atomika Teknik, 6 Ocak 2015, Mövenpick Hotel, Ankara, Türkiye.
  • Araştırma Görevlileri için Eğiticilerin Eğitimi, 24 Kasım-25 Aralık 2014, ATAUM, Ankara, Türkiye.
  • Agilent Technologies Cary 630 Model FTIR Sistemi ve Software Eğitimi, 27 Ekim 2014, Ankara Üniversitesi Eczacılık Fakültesi, Ankara, Türkiye.
  • II. Çevre Günleri – Sürdürülebilir Enerji Sempozyumu, 05 Haziran 2014, Ankara Üniversitesi Rektörlüğü, Ankara, Türkiye.
  • SEM – Agilent Spektroskopi Çözümleri Semineri, 08 Mayıs 2014, Swissotel, Ankara, Türkiye.
  • Interlab and Sigma-Aldrich Seminer Series: Sigma Life Science – Where Bio Begins, 18 March 2014, Hilton Hotel, Ankara, Turkey.
  • Chemometrics Course, NTCA-2013, 23-25 October 2013, Ankara University, Faculty of Pharmacy, Ankara, Turkey.
  • Siber Güvenlik Farkındalık Eğitimi, ISCTurkey 2013 Konferansı, 21 Eylül 2013, ODTÜ, Ankara, Türkiye.
  • İlaç Araştırmalarında Uygulamalı Moleküler Modelleme ve Simülasyon Teknikleri Kursu, MAGUM, 20-22 Şubat 2013, Hacettepe Üniversitesi, Ankara, Türkiye.
  • Computational Drug Discovery, Schrödinger Workshop, 26-27 April 2012, Yeditepe University, Istanbul, Turkey.
  • Ankara Biyoteknoloji Günleri, Mikrobiyal Biyoteknoloji, 17-18 Ekim 2011, Ankara Üniversitesi Rektörlüğü, Ankara, Türkiye.
  • Meslek İçi Eğitim Programı (MİEP), 15-16 Aralık 2010, Ankara, Türkiye.
  • 2nd Workshop on Computer Aided Drug Design & Development – Molecular Modeling (WCADD-2), 26-29 June 2008, Başkent University, Ankara, Turkey.
  • Bilgisayar Destekli İlaç Tasarımı ve Geliştirilmesi – 1, Kantitatif Yapı-Etki İlişkileri (WCADD-1), 02-05 Şubat 2007, Koç Üniversitesi, İstanbul, Türkiye.
  • Molecular Operating Environment (MOE) kullanıcı grubu seminerleri, 27-28 Nisan 2006, Ankara/TÜRKİYE

Memberships

  • Turkish Pharmacists' Association 2nd District Chamber of Pharmacist of Ankara 
  • Turkish Association of Pharmaceutical and Medicinal Chemistry 
  • Computer Aided Drug Design & Development Association in Turkey
  • Pharmaceutical Researchers and Practitioners Association in Turkey

Computer Skills

  •  MS Office Applications
  •  Adobe Applications (Macromedia App.) 
  •  Internet Applications
  •  Corel Applications 
  •  Discovery Studio

Artículos Científicos

  • 28
    Tugba Ertan Bolelli, Kayhan Bolelli, Cisem Altunayar-Unsalan, Ozan Unsalan, “Effects of flavonoids on SARS–CoV–2 main protease (6W63): A molecular docking study”, Turkish Comp Theo Chem (2022) In press.
  • 27
    Tugba Ertan-Bolelli, Kayhan Bolelli, Sitki Doga Elci, F. Burcu Belen-Apak, “Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin”, Cardiovascular Drugs and Therapy, ( Nov 2022). DOI: 10.1007/s10557-022-07406-z
  • 26
    Ronak Haj Ersan, Kayhan Bolelli, Serpil Gonca, Aylin Dogen, Serdar Burmaoğlu, Oztekin Algul, “Bisbenzimidazole Derivatives as Potential Antimicrobial Agents: Design, Synthesis, Biological Evaluation and Pharmacophore Analysis”, Pharmaceutical Chemistry Jourmal, 55 (2), 149-158 (6 Mar 2021). DOI: 10.1007/s11094-021-02389-x
  • 25
    Kayhan Bolelli, Tugba Ertan-Bolelli, Ozan Unsalan, Cisem Altunayar-Unsalan, “Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study”, Journal of Molecular Structure, 1228, 129449 (15 March 2021). DOI: 10.1016/j.molstruc.2020.129449
  • 24
    Tugba Ertan-Bolelli, Kayhan Bolelli “In silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span”, Current Computer-Aided Drug Design, 17 (3), 412-420 (2021). DOI: 10.2174/1573409916666200422074441
  • 23
    Y. Sheena Mary, Tugba Ertan-Bolelli, Renjith Thomas, Akhil R. Krishnan, Kayhan Bolelli, Esin Nagihan Kasap, Tijen Önkol, İlkay Yıldız, “Quantum Mechanical Studies of Three Aromatic Halogen-Substituted Bioactive Sulfonamidobenzoxazole Compounds with Potential Light Harvesting Properties”, Polycyclic Aromatic Compounds, 41(7), 1563-1579 (2021). DOI: 10.1080/10406638.2019.1689405 [texto íntegro]
  • 22
    Ozan Unsalan, Hatice Arı, Cisem Altunayar-Unsalan, Kayhan Bolelli, Mustafa Boyukata, Ismail Yalcin, “FTIR, Raman and DFT studies on 2-[4-(4-ethylbenzamido)phenyl]benzothiazole and 2-[4-(4-nitrobenzamido)phenyl]benzothiazole supported by differential scanning calorimetry”, Journal of Molecular Structure, 1218, 128454 (Oct 2020). DOI: 10.1016/j.molstruc.2020.128454 [texto íntegro]
  • 21
    Kayhan Bolelli, “Design of Sulfonamidobenzothiazole Derivatives as hGSTP1-1 Inhibitors”, Journal of Faculty of Pharmacy of Ankara University, 44(3), 388-396 (2020). [in Turkish] DOI: 10.33483/jfpau.748521
  • 20
    Tugba Ertan Bolelli, Kayhan Bolelli, “Pharmacophore Modeling Studies on Known Mmp-9 Enzyme Inhibitors to Identify the Important Common Features”, Journal of Faculty of Pharmacy of Ankara University, 44(2), 204-210 (2020). DOI: 10.33483/jfpau.690373
  • 19
    Mustafa Lawar, Safia ElBadwe, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli, “Comparative Study of CBS-Q Calculated and Experimental pKa Values for Fluoro-Acetoxy Derivative”, Asian Journal of Chemical Sciences, 6(2), 1-12 (2019). Article No. AJOCS.47995 DOI: 10.9734/ajocs/2019/v6i218991 [texto íntegro]
  • 18
    Tugba Ertan-Bolelli, Kayhan Bolelli, "Discovery of New DNA Topoisomerase II Inhibitors using Structure Based Virtual Screening Method", JOTCSA, 6(1), 71-78 (2019). DOI: https://dx.doi.org/10.18596/jotcsa.466457 [texto íntegro]
  • 17
    Kayhan Bolelli, Tugba Ertan-Bolelli, "Pharmacophore-Based Virtual Screening of Novel GSTP1-1 Inhibitors", JOTCSA, 5(3), 1279-1286 (2018). DOI: 10.18596/jotcsa.466458 [texto íntegro]
  • 16
    Mustafa Lawar, Safia Badwe, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli, “Quantum Chemical Studies on Some Thiosemicarbazone Derivatives as Ribonucleotide Reductase Inhibitor”, Asian Journal of Chemical Sciences, 4(4), 1-13 (2018). Article No. AJOCS.42832 DOI: 10.9734/AJOCS/2018/42832 [texto íntegro]
  • 15
    Tugba Ertan-Bolelli*, Kayhan Bolelli, Yaman Musdal, Ilkay Yildiz, Esin Aki-Yalcin, Bengt Mannervik, Ismail Yalcin, "Design and synthesis of 2-substituted-5-(4-trifluoromethylphenylsulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors", Artificial Cells, Nanomedicine, and Biotechnology, 46(3), 510-517 (2018). Doi: 10.1080/21691401.2017.1324464 [texto íntegro]
  • 14
    Kayhan Bolelli, Yaman Musdal, Esin Aki-Yalcin, Bengt Mannervik, Ismail Yalcin*, "Synthesis and Activity Mechanism of Some Novel 2-­Substituted Benzothiazoles as hGSTP1­1 Enzyme Inhibitors", SAR and QSAR in Environmental Research, 28(11), 927-940 (2017). DOI: 10.1080/1062936X.2017.1402820 [texto íntegro]
  • 13
    Ozum Ozturk, Esin Aki-Yalcin*, Tugba Ertan-Bolelli, Kayhan Bolelli, Andry Nur Hidayat, Ozlem Bingol-Ozakpinar, Filiz Ozdemir, Ismail Yalcin, “Possible Mechanism of Action of Neurokinin-1 Receptors (NK1R) Antagonists”, Journal of Pharmacy and Pharmacology, 5(11), 787-797 (2017). DOI: 10.17265/2328-2150/2017.11.001 [texto íntegro]
  • 12
    Tugba Ertan-Bolelli*, Kayhan Bolelli, Suzan Okten, Fatma Kaynak-Onurdag, Esin Aki-Yalcin, Ismail Yalcin, "Synthesis, Antimicrobial Activities of New Sulfonamidobenzoxazoles and Molecular Docking Studies on Escherichia coli TEM-1 β-Lactamase", Croatica Chemica Acta, 90(1), 67-74 (2017). DOI: 10.5562/cca3111 [texto íntegro]
  • 11
    Ugur Senel, Tugba Ertan-Bolelli*, Kayhan Bolelli, Ilkay Yildiz, "Docking Studies on Enoyl-Acyl Carrier Protein (ACP) Reductase Enzyme Inhibitors", Journal of Faculty of Pharmacy of Ankara University, 40(1), 25-35 (2016). Doi: 10.1501/Eczfak_0000000577 | [in Turkish] [texto íntegro]
  • 10
    Emine Oksuzoglu*, Egemen Foto, Fatma Zilifdar, Tugba Ertan-Bolelli, Kayhan Bolelli, “Antiproliferative and Genotoxic Activities in L929 and HeLa Cell Lines - the Mutagenic Effects in Salmonella Strains of Novel Benzoxazole Derivatives”, Latin American Journal of Pharmacy, 35(10), 2216-2224 (2016). [texto íntegro]
  • 9
    Serap Yilmaz, Gulsen Altinkanat-Gelmez, Kayhan Bolelli, Deniz Guneser-Merdan, M. Ufuk Over-Hasdemir, Esin Aki-Yalcin, Ismail Yalcin, "Binding Site Feature Description of 2-Substituted Benzothiazoles as AcrAB-TolC Efflux Pump Inhibitors in E. coli", SAR and QSAR in Environmental Research, 26(10), 853-871 (2015). DOI:10.1080/1062936X.2015.1106581 [texto íntegro]
  • 8
    ERTAN-BOLELLI, T., MUSDAL, Y., BOLELLI, K., YILMAZ, S., AKSOY, Y., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Synthesis, Biological Evaluation of 2-Substituted-5-(4-nitrophenylsulfonamido) benzoxazoles as Human GST P1-1 Inhibitors and Description of the Binding Site Features”, ChemMedChem,9(5), 984-992, (2014). doi:10.1002/cmdc.201400010 [texto íntegro]
  • 7
    YILMAZ, S., ALTINKANAT-GELMEZ, G., BOLELLI, K., GUNESER-MERDAN, D., OVER-HASDEMIR, M. U., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Pharmacophore Generation of 2-Substituted Benzothiazoles as AdeABC Efflux Pump Inhibitors in A. baumannii”, SAR and QSAR in Environmental Research, 25(7), 551-563, (2014). doi:10.1080/1062936X.2014.919357 [texto íntegro]
  • 6
    UNSALAN, O., SERT, Y., ARI, H., SIMÃO, A., YILMAZ, A., BOYUKATA, M., BOLUKBASI, O., BOLELLI, K., YALCIN, I., “Micro-Raman, Mid-IR, Far-IR and DFT studies on 2-[4-(4-Fluorobenzamido)phenyl]benzothiazole”, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 125, 414-421, (2014). doi:10.1016/j.saa.2014.01.118 [texto íntegro]
  • 5
    BHAGYASREE, J.B., VARGHESE, H.T., PANICKER, C.Y., SAMUEL, J., VAN ALSENOY, C., BOLELLI, K., YILDIZ, I., AKI, E., "Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole", Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 102, 99-113, (2013). doi:10.1016/j.saa.2012.09.032 [texto íntegro]
  • 4
    MUSDAL, Y., ERTAN-BOLELLI, T., BOLELLI, K., YILMAZ, S., CEYHAN, D., HEGAZY, U., MANNERVIK, B., AKSOY, Y., "Inhibition of human glutathione transferase P1-1 by novel benzazole derivatives", Turk. J. Biochem., 37(4), 431-436, (2012). doi: 10.5505/tjb.2012.30301 [texto íntegro]
  • 3
    BOLELLI, K., YALCIN, I., ERTAN-BOLELLI, T., OZGEN, S., KAYNAK-ONURDAG, F., YILDIZ, I, AKI, E., "Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido)phenyl]benzothiazoles as antimicrobial agents", Med. Chem. Res., 21, 3818-3825, (2012). DOI: 10.1007/s00044-011-9918-4 [texto íntegro]
  • 2
    ERTAN, T., YILDIZ, I., TEKINER-GULBAS, B., BOLELLI, K., TEMIZ-ARPACI, O., OZKAN, S., KAYNAK, F., YALCIN, I., AKI, E., “Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents”, European Journal of Medicinal Chemistry, 44, 501–510, (2009). doi:10.1016/j.ejmech.2008.04.001 [texto íntegro]
  • 1
    YILDIZ, I., ERTAN, T., BOLELLI, K., TEMIZ-ARPACI, O.,YALCIN, I. AKI, E., "QSAR and Pharmacophore Analysis on Amides against Drug-Resistant S. aureus", SAR and QSAR in Environmental Research, 19(1-2), 101-113, (2008). DOI: 10.1080/10629360701844159 [texto íntegro]

Artículos de Revisión

  • 1
    Nathanael K. Proctor, Tugba Ertan-Bolelli, Kayhan Bolelli, Ethan W. Taylor, Norman H. L. Chiu, J. Phillip Bowen, “Towards a Better Understanding of Computational Models for Predicting DNA Methylation Effects at the Molecular Level”, Current Topics in Medicinal Chemistry, 20(10), 901-909 (Feb 2020). DOI : 10.2174/1568026620666200226110019 [texto íntegro]

Presentaciones Orales

  • 50
    Ismail Yalcin*, Esin Aki-Yalcin, Kayhan Bolelli, Tugba Ertan Bolelli, Yaman Musdal, Bengt Mannervik. Structure-activity relationship analysis of some new benzazoles as hGSTP1-1 enzyme inhibitors, 10th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI 2019), Ioannina, Greece, C19: p27, 23-27 June 2019.
  • 49
    Ismail Yalcin*, Esin Aki-Yalcin, Kayhan Bolelli, Tugba Ertan Bolelli, Yaman Musdal, Bengt Mannervik. Structure-Activity Relationship Analysis of Some New Benzothiazole and Benzoxazole Derivatives as hGST P1-1 Enzyme Inhibitors, 6th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IL-13: p16-p17, 13-15 December 2018.
  • 48
    Esin Aki-Yalcin*, Ozum Ozturk, Kayhan Bolelli, Serap Yilmaz, Ozlem Bingol-Ozakpinar, Filiz Ozdemir, Ismail Yalcin. Synthesis, cytotoxic activities of some benzazoles, and description of activity mechanism as Neurokinin-1 (NK1) receptors antagonists, The 70th Southeastern Regional Meeting of the American Chemical Society (SERMACS 2018), Augusta, GA, USA, 457: p208, October 31-November 3, 2018.
  • 47
    Ilkay Yildiz*, Serap Yilmaz, Sanaz Ataei, Tugba Ertan-Bolelli, Kayhan Bolelli, Fatma Zilifdar, Egemen Foto. Molecular Modelling Studies on Benzoxazines as Anticancer Agents, International Chemistry & Biology Conference’18 (ChemBioCon’18), Sharm El-Sheikh, Egypt, OP-05: p22, 11-14 July 2018.
  • 46
    Aki-Yalcin*, E., Yilmaz, S., Bolelli, K., Ozturk, O., Ertan-Bolelli, T., Taskin-Tok, T., Yalcin, I. Design and Activity Mechanism Description of Anticancer Active Benzazoles against DNA Topoisomerase-II by using Molecular Modeling Techniques, 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), Ankara, Turkey, PL-14: p9, 26-29 June 2018.
  • 45
    Kayhan Bolelli*, Ismail Yalcin. Synthesis, Structure Elucidation, GST Enzyme Inhibitor Activity and Investigation of Activity Mechanistic Dynamics of Some New Benzothiazole Derivatives, V. National Pharmaceutical Chemistry Congress (NPCC-5), Ataturk University, Erzurum, Turkey, 28 April-01 May 2018. [In Turkish]
  • 44
    Ismail Yalcin*, Kayhan Bolelli, Esin Aki-Yalcin, Yaman Musdal, Bengt Mannervik. Structure-Activity Relationship Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI 2017), Bogmallo Beach Resort, Goa, India, IL-13: p32, 27-30 October 2017.
  • 43
    Ismail Yalcin*, Serap Yılmaz, Kayhan Bolelli, Ozum Ozturk, Esin Aki-Yalcin. Structure-Activity Relationship Analysis of Some Banzazoles as Topo II Enzyme Inhibitors, 5th International BAU Drug Design Congress, Bahçeşehir University, School of Medicine, Istanbul, Turkey, IS-18: p27, 19-21 October 2017.
  • 42
    Esin Aki-Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Andry Nur Hidayat, Ismail Yalcin. Computer Aided Drug Design Studies on Benzazoles Active against Topo II Enzyme as an Anticancer Target, 2nd International Gazi Symposium Series (GPSS 2), Gazi University Faculty of Pharmacy, Ankara, Turkey, O41: p67, 11-13 October 2017.
  • 41
    Mustafa Lawar*, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli. QSAR Study on Thiosemicarbazone Derivatives as Ribonucleotide Reductase Inhibitors, Sixth Bozok Science Workshop (BSW 2017), Bozok University, Art and Science Faculty, Yozgat, Turkey, p37-38, 23-25 August 2017.
  • 40
    Ismail Yalcin*, Kayhan Bolelli, Esin Aki-Yalcin, Yaman Musdal, Bengt Mannerick. Binding Site Description Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 17th Hellenic Symposium on Medicinal Chemistry (HSMC-2017), Aristotle University of Thessaloniki, Thessaloniki, Greece, ML8: p13, 1-3 June 2017.
  • 39
    Ismail Yalcin*, Serap Yilmaz, Kayhan Bolelli, Esin Aki-Yalcin. Binding Site Description Studies of 2-Substituted Benzothiazoles as the Novel RND Efflux Pump Inhibitors, 4rd International Conference on Computation for Science and Technology (ICCST) 2016, De Baron Resort, Langkawi, Malaysia, PLN5: p49, 3-4 November 2016.
  • 38
    Ismail Yalcin*, Kayhan Bolelli, Yaman Musdal, Esin Aki-Yalcin. Structure-Activity Relationship Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 4th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IS-24: p32, 13-15 October 2016.
  • 37
    Emine Oksuzoğlu*, Egemen Foto, Fatma Zilifdar, Tugba Ertan-Bolelli, Kayhan Bolelli. A study on antiproliferative and genotoxic potentials in L929 and HeLa cell lines -the mutagenic activities in Salmonella strains of novel 2,5-disubstitutedbenzoxazole derivatives, 41st FEBS Congress, Ephesus, Kuşadası, Turkey, ST-05.01.1-004: p85, 03-08 September 2016.
  • 36
    Esin Akı Yalçın*, Serap Yılmaz, Kayhan Bolelli, Özüm Öztürk, Tuğba Ertan-Bolelli, İsmail Yalçın, The Role of Chemometrics in Computer Aided Drug Design Studies, 3rd International Conference on New Trends in Chemometrics and Applications (NTCA-2016), Side, Antalya, Turkey, IL-02: p4, May 25-28, 2016.
  • 35
    Özüm Öztürk*, Esin Akı-Yalçın, Kayhan Bolelli, İsmail Yalçın. Nörokinin-1 Reseptör Antagonistlerinin Moleküler Modelleme Çalışmaları, 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, S-2: p11, 16-17 Mayıs 2016.
  • 34
    Kayhan Bolelli*, Yaman Musdal, Esin Aki-Yalcin, Ismail Yalcin. Bazı Yeni Benzotiyazol Türevi Bileşiklerin GST Enzimi üzerine Etkileri ve Doking Çalışmaları, 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, S-9: p19, 16-17 Mayıs 2016.
  • 33
    Esin Aki-Yalcin, Ismail Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk. Molecular Modeling Application by using Discovery Studio, BIOVIA Turkish Regional User Meeting with A-Ztech Ltd., ByOtell Hotel, Istanbul, Turkey, 6 May 2016.
  • 32
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk and Tugba Ertan Bolelli. Enzyme Binding Site Description of AcrAB-TolC Efflux Pump Inhibitors, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-1: p253, 18-21 October 2015.
  • 31
    E. Aki-Yalcin, O. Ozturk, T. Ertan-Bolelli, K. Bolelli, S. Yilmaz, A. H. Nur, O. Bingol-Ozakpinar, and F. Ozdemir. Mechanism of Action of Some New Anticancer Active Neurokinin-1 (NK1) Receptor Antagonists, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-4: p256, 18-21 October 2015.
  • 30
    Ismail Yalcin, Serap Yilmaz, Gulsen Altinkanat-Gelmez, Kayhan Bolelli, Deniz Guneser-Merdan, M. Ufuk Over-Hasdemir, Esin Aki-Yalcin. Binding Site Description Of Benzothiazoles As the RND Efflux Pump Acrb Inhibitors, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-14: p30, 1-3 October 2015.
  • 29
    Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan-Bolelli, Andry Nur Hidayat, Ozlem Bingol-Ozakpinar, Filiz Ozdemir, Ismail Yalcin. Mechanism of Action of Neurokinin-1 Receptors as an Anticancer Target, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-22: p39-40, 1-3 October 2015.
  • 28
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Tugba Ertan-Bolelli, Esin Aki-Yalcin. Description of the Binding Site Features of AcrAB-TolC Efflux Pump Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-11: p44, 21-25 June 2015.
  • 27
    Esin Akı-Yalcin, Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, A.H. Nur, S. Sahin, Ismail Yalcin, Ozlem Bingol-Ozakpinar, Filiz Ozdemir. Molecular Modeling Studies on Neurokinin 1 (NK1) Receptors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-12: p47, 21-25 June 2015.
  • 26
    Esin Aki-Yalcin, Ismail Yalcin, Tugba Ertan-Bolelli, Serap Yilmaz, Kayhan Bolelli, Özüm Öztürk, Tugba Taskin-Tok, Emine Öksüzoglu, Cigdem Özen-Kaplan. Computer aided drug design studies for new anticancer drugs, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, Closing Lecture: p38, 18-19 May 2015.
  • 25
    Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ismail Yalcin, Esin Aki-Yalcin. Molecular Docking Analysis of Benzothiazole/Benzothiazolium Derivatives as Human DNA Topoisomerase II Inhibitors, BIOVIA Turkish Regional User Meeting with A-Ztech Ltd., ByOtell Hotel, Istanbul, Turkey, 10 April 2015.
  • 24
    Ismail Yalcin, Tugba Ertan-Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Computer Aided Molecular Modeling of the Binding Site and GSH Conjugation Features of the New Human GST P1-1 Inhibitors, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, PL-03: p6, 23-25 September 2014.
  • 23
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Tugba Taskin-Tok, Andry Nur Hidayat, Ilkay Yildiz, Ismail Yalcin. Anticancer Drug Design Studies using Molecular Modeling Techniques, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, IS-02: p10, 23-25 September 2014.
  • 22
    Tugba Ertan-Bolelli, Ismail Yalcin, Yaman Musdal, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Molecular Docking Studies on Human Glutathione S-transferase Enzyme (hGSTP1-1), The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P13: p28, 23-25 September 2014.
  • 21
    Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, Esin Aki-Yalcin, Ismail Yalcin. Computational Drug Design Studies for Multidrug Resistance AcrAB-TolC Efflux Pump Inhibitors on Escherichia coli, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P106: p62, 23-25 September 2014.
  • 20
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Tugba Taskin-Tok, Cigdem Ozen, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Ilkay Yildiz, Ismail Yalcin. Identification of Mechanism of Action of DNA-Topoisomerase II Inhibitors by Molecular Modeling Studies, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, OC12: p52, 31 August - 4 September 2014.
  • 19
    Ismail Yalcin, Tugba Ertan-Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Description of the Binding Site Features of Some Fused Heterocycles as New Human GST P1-1 Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-5: p9, 17-19 April 2014.
  • 18
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Tugba Taskin-Tok, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Ilkay Yildiz and Ismail Yalcin. Molecular Modeling Studies on DNA-Topoisomerase II Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IL-8: p18, 17-19 April 2014.
  • 17
    Esin Aki-Yalcin, Ismail Yalcin, Ilkay Yildiz, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Özüm Öztürk. Chemometrics in Drug Design, 2nd International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, IL-05: p7, 25-28 October 2013.
  • 16
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Tugba Taskin-Tok, Ilkay Yildiz and Ismail Yalcin. Rational Design of DNA-Topoisomerase Inhibitory Active Benzazoles as Antitumoral Agents, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, O-37: p54, 15-18 October 2013.
  • 15
    Ismail Yalcin, Kayhan Bolelli, Serap Yilmaz, Tugba Ertan-Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, Esin Aki-Yalcin. CADD Studies on Chemotherapeutical Active Fused Heterocyclic Compounds, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, S18-01: p55, 15-18 October 2013.
  • 14
    Esin Aki, Tugba Taskin, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Ilkay Yildiz, Ismail Yalcin, Yaman Musdal, Yasemin Aksoy. Molecular Modelling Studies on the Design of Chemotherapeutically Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26, 21-23 March 2013.
  • 13
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Tugba Ertan-Bolelli, Ilkay Yildiz, Esin Aki-Yalcin. Common Feature Pharmacophore Generation of Heterocyclic Compounds as Bacterial RND Efflux Pump Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-2: p27, 21-23 March 2013.
  • 12
    Ismail Yalcin, Esin Aki, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, and Serap Yilmaz. Computational Methods in Rational Drug Design, 2nd International Conference on Computation for Science and Technology (ICCST-II), Nigde, Turkey, Plenary Lec-5: p43, 09-11 July 2012.
  • 11
    Esin Akı, İsmail Yalçın, Ilkay Yildiz, Tuğba Taşkın, Tuğba Ertan-Bolelli, Serap Yilmaz, Kayhan Bolelli. Structure Based Drug Design Methods, 2nd International Conference on Computation for Science and Technology (ICCST-II), Nigde, Turkey, Invited Lec-7: p52, 09-11 July 2012.
  • 10
    Ismail Yalcin, Esin Aki, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, and Serap Yilmaz. QSAR and Molecular Modeling Studies on Chemotherapeutic Active Benzazoles, 8th AFMC International Medicinal Chemistry Symposium (AIMECS 11), Keio Plaza Hotel, Tokyo, Japan, IL-B1: p8, 29 November-2 December 2011.
  • 9
    Esin Aki, Ismail Yalcin, Ilkay Yildiz, Betul Tekiner-Gulbas, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Sanaz Ataei, Özüm Öztürk. Chemometrics in Drug Design, 1st International Conference on New Trends in Chemometrics and Applications (NTCA-2011), Side, Antalya, Turkey, IL-05: p7, October 08-11, 2011.
  • 8
    Esin Aki, Tugba Taskin, Yaman Musdal, Yasemin Aksoy, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, İlkay Yildiz, İsmail Yalcin. Docking Studies of GST Inhibitory Active 2-Substituted Benzazoles, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2011), Maribor, Slovenia, MT-07: p43, 03-07 September 2011.
  • 7
    Ismail Yalcin, Kayhan Bolelli, Serap Yilmaz, İlkay Yildiz, and Esin Aki-Yalcin. Common Feature Pharmacophore Generation of Heterocyclic Compounds against Efflux Pump Over-expressor Bacteria, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2011), Maribor, Slovenia, OC-21: p67, 03-07 September 2011.
  • 6
    Esin Akı, İsmail Yalçın, İlkay Yıldız, Tugba Ertan-Bolelli, Kayhan Bolelli, Tugba Taşkın, Serap Yılmaz. Kemoterapötik Etkili Heterosiklik Bileşiklerin Bilgisayar Destekli İlaçTasarım Çalışmaları, Uluslararası Katılımlı 25. Ulusal Kimya Kongresi (UKK-25), Atatürk Üniversitesi, Erzurum, Türkiye, IL-009: p43, 27 Haziran - 02 Temmuz 2011.
  • 5
    Tugba Taskin-Tok, Esin Akı, Ismail Yalcin, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz. Docking Studies of Topoisomerase II Inhibitors, Uluslararası Katılımlı 25. Ulusal Kimya Kongresi (UKK-25), Atatürk Üniversitesi, Erzurum, Türkiye, MS-013: p180, 27 Haziran - 02 Temmuz 2011.
  • 4
    Esin Aki, İsmail Yalçin, İlkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz. Computational Drug Design Studies on Antitumoral Active Heterocyclic Compounds, 18th European Symposium on Quantitative Structure-Activity Relationships (18th EuroQSAR), Rhodes, Greece, OP27: p84, 19-24 September 2010.
  • 3
    Esin Akı, İsmail Yalçın, İlkay Yildiz, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz. Computer Aided Drug Design Studies on Chemotherapeutically Active Heterocyclic Compounds, Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), Istanbul, Turkey, PL-2: p16, 9-12 June 2010.
  • 2
    Esin Aki, İsmail Yalcin, İlkay Yildiz, Özlem Temiz-Arpaci, Kayhan Bolelli, Tugba Ertan-Bolelli. DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships, Current Trends in Drug Discovery Research (CTDDR-2010), Med Chem Res (2010), Lucknow, India, 19(Suppl.1): S6, 17-21 February 2010.
  • 1
    Ilkay Yıldız, Tugba Ertan, Ozlem Temiz-Arpaci, Kayhan Bolelli, Esin Aki-Sener, Ismail Yalcin. Three-Dimensional Common-Feature Hypotheses and 2D-QSAR Studies on Some Antimicrobiologically Active Amides against Drug-Resistance Staphylococcus aureus, Fourth International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2007), Moscow, Russia, OC-15: p52, 1-5 September 2007.

Presentaciones Diapositivas

  • 74
    Kayhan Bolelli, Ismail Yalcin*, Tugba Ertan-Bolelli, Yaman Musdal, Bengt Mannervik, Esin Aki-Yalcin. Synthesis and binding interactions of some newly 2-benzamidobenzothiazoles on hGSTP1-1 enzyme, The 70th Southeastern Regional Meeting of the American Chemical Society (SERMACS 2018), Augusta, GA, USA, 538: p244, October 31-November 3, 2018.
  • 73
    Tugba Ertan-Bolelli, Kayhan Bolelli, Bilgehan Doğru*, Ilkay Yildiz. Docking studies of some sulfonamidobenzoxazole derivatives on aldose reductase enzyme, 4th International Turkic World Conference on Chemical Sciences and Technologies (ITWCCST2018), Ramada Encore Hotel, Kiev, Ukraine, PP: p, 7-10 September 2018.
  • 72
    Kayhan Bolelli*, Tugba Ertan-Bolelli, Bilgehan Doğru, Ilkay Yildiz. Molecular Modeling Studies on some Aldose Reductase Enzyme Inhibitors, International Chemistry & Biology Conference’18 (ChemBioCon’18), Sharm El-Sheikh, Egypt, PP-42: p89, 11-14 July 2018.
  • 71
    Kayhan Bolelli*, Tugba Ertan-Bolelli. Pharmacophore-Based Virtual Screening of Novel GSTP1-1 Inhibitor, International Chemistry & Biology Conference’18 (ChemBioCon’18), Sharm El-Sheikh, Egypt, PP-48: p95, 11-14 July 2018.
  • 70
    Tugba Ertan-Bolelli*, Kayhan Bolelli. Discovery of New DNA Topoisomerase II Inhibitors using Structure Based Virtual Screening Method, International Chemistry & Biology Conference’18 (ChemBioCon’18), Sharm El-Sheikh, Egypt, PP-49: p96, 11-14 July 2018.
  • 69
    Bolelli, K.*, Ertan-Bolelli, T., Yalcin, I. In silico Studies of Some 2-Amino Benzothiazole Derivatives as Aldose Reductase Enzyme Inhibitors, 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), Ankara, Turkey, P-458: p386, 26-29 June 2018.
  • 68
    T. Ertan-Bolelli*, K. Bolelli, Y. Musdal, I. Yildiz, E. Aki Yalcin, B. Mannervik, I. Yalcin. Docking studies of 2-substituted-5-(4-trifluoromethylphenylsulfonamido) benzoxazole derivatives on human GST P1-1 enzyme, The 69th Southeastern Regional Meeting of the American Chemical Society (SERMACS 2017), Sheraton Charlotte Hotel, Charlotte, NC, USA, 95: p36, November 7-11, 2017.
  • 67
    K. Bolelli*,T. Ertan-Bolelli, I. Yalcin. Docking studies of some benzothiazole derivatives on aldose reductase enzyme, The 69th Southeastern Regional Meeting of the American Chemical Society (SERMACS 2017), Sheraton Charlotte Hotel, Charlotte, NC, USA, 98: p36, November 7-11, 2017.
  • 66
    Kayhan Bolelli, Ismail Yalcin*, Tugba Ertan-Bolelli, Yaman Musdal, Bengt Mannervik, Esin Aki-Yalcin. Microwave Synthesis and hGST P1-1 Enzyme Inhibitor Activities of Some Novel Benzothiazole Deivatives, 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI 2017), Bogmallo Beach Resort, Goa, India, P-02: p51, 27-30 October 2017.
  • 65
    Kayhan Bolelli, Tugba Ertan-Bolelli, Bilgehan Dogru*, Ilkay Yildiz. Molecular Docking Studies of 2,5-Disubstituted Benzoxazole Derivatives as Aldose Reductase Enzyme Inhibitor, 3rd International Turkic World Conference on Chemical Sciences and Technologies (ITWCCST2017), Baku, Azerbaijan, PO-19: p163, September 10-13, 2017.
  • 64
    Kayhan Bolelli*, Hatice Ari, Mustafa Boyukata, Ismail Yalcin, Ozan Unsalan. Molecular Structure and Vibrational Spectroscopic Study of 2-[4-(4-Nitrobenzamido)phenyl]benzothiazole using DFT Method, III. International Turkish Congress on Molecular Spectroscopy (TURCMOS 2017), Nasuhoglu Cultural Center, Mugla University, Bodrum, Turkey, P-036: p157, 26-29 August 2017.
  • 63
    Ismail Yalcin*, Kayhan Bolelli, Yaman Musdal, Bengt Mannervik, Esin Aki-Yalcin. Binding Properties of Some New hGST P1-1 Inhibitor Benzothiazoles, 11th AFMC International Medicinal Chemistry Symposium (AIMECS2017), Melbourne, Australia, p86, 23-26 July 2017.
  • 62
    Ozum Ozturk, Esin Aki-Yalcin*, Kayhan Bolelli, Ismail Yalcin. Molecular Docking Studies Of Neurokinin-1 Receptor Antagonists, 11th AFMC International Medicinal Chemistry Symposium (AIMECS2017), Melbourne, Australia, p128, 23-26 July 2017.
  • 61
    Kayhan Bolelli, Ismail Yalcin*, Esin Aki-Yalcin, Tugba Ertan-Bolelli, Yaman Musdal, Bengt Mannervik. Synthesis, Structure Elucidation and hGSTP1-1 Inhibitor Activity of Some Benzothiazoles, 11th AFMC International Medicinal Chemistry Symposium (AIMECS2017), Melbourne, Australia, p170, 23-26 July 2017.
  • 60
    Kayhan Bolelli, Ismail Yalcin*, Tugba Ertan-Bolelli, Esin Aki-Yalcin, Yaman Musdal, Bengt Mannerick. Design, Synthesis and Structure Elucidation of Some Novel Benzothiazole Derivatives, as the hGSTP1-1 Enzyme Inhibitors, 17th Hellenic Symposium on Medicinal Chemistry (HSMC-2017), Aristotle University of Thessaloniki, Thessaloniki, Greece, P10: p52, 1-3 June 2017.
  • 59
    Kayhan Bolelli*, Tugba Ertan-Bolelli, Ismail Yalcin. Pharmacophore Identification Analysis on Known SIRT1 Enzyme Activators, 2nd Scripps Florida Symposium on Biology of Aging: Advances in Therapeutic Approaches to Extend Healthspan, The Scripps Research Institute, Jupiter, Florida, USA, P-3: p3, January 22-25, 2017.
  • 58
    Tugba Ertan-Bolelli*, Kayhan Bolelli, Ilkay Yildiz. Molecular Docking Studies on SIRT1 Enzyme, 2nd Scripps Florida Symposium on Biology of Aging: Advances in Therapeutic Approaches to Extend Healthspan, The Scripps Research Institute, Jupiter, Florida, USA, P-9: p9, January 22-25, 2017.
  • 57
    Kayhan Bolelli*, Ismail Yalcin, Yaman Musdal, Esin Aki-Yalcin. Design and Synthesis of Some New Benzothiazole Derivatives, as the hGSTP1-1 Enzyme Inhibitors, 4th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, PP-70: p213, 13-15 October 2016.
  • 56
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Esin Aki-Yalcin, Ufuk Over-Hasdemir. Binding site description of 2-substituted benzothiazoles as potential RND efflux pump inhibitors, 6th Congress of Pharmacy in Macedonia, Ohrid, Macedonia, S6 PP 259: p543-544, June 1-5, 2016.
  • 55
    Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Ismail Yalcin. Docking studies of neurokinin-1 receptor antagonists as an anticancer target, 6th Congress of Pharmacy in Macedonia, Ohrid, Macedonia, S6 PP 264: p553-554, June 1-5, 2016.
  • 54
    Kayhan Bolelli, Yaman Musdal, Esin Aki-Yalcin, Ismail Yalcin. Docking Studies of Some Heterocyclic Compounds on Glutation S-Transferase Enzyme, 3rd International Conference on New Trends in Chemometrics and Applications (NTCA-2016), Side, Antalya, Turkey, PP-74: p156, May 25-28, 2016.
  • 53
    Tugba Ertan-Bolelli, Yaman Musdal, Bengt Mannervik, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Ilkay Yildiz, Esin Aki-Yalcin, Ismail Yalcin. Design and Synthesis of Novel sulfonamide-containing benzoxazoles as Human GST P1-1 Inhibitors, Challenges in Organic Chemistry (ISACS19), Irvine, Los Angeles, California, USA, P15, 20-23 March 2016.
  • 52
    Kayhan Bolelli, Tugba Ertan-Bolelli, Serap Yilmaz, Ozum Ozturk, Esin Aki-Yalcin, Ismail Yalcin. Pharmacophore Identification Analysis on hGST P1-1 Enzyme Inhibitory Active Benzothiazole Derivatives, Challenges in Organic Chemistry (ISACS19), Irvine, Los Angeles, California, USA, P33, 20-23 March 2016.
  • 51
    Ozum Ozturk, Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ismail Yalcin. Molecular Modeling Studies of Neurokinin-1 Receptor Antagonists, The International Chemical Congress of Pacific Basin Societies 2015 (Pacifichem-2015), Honolulu, Hawaii, USA, 10-HLTH-450: p294, 15-20 December 2015.
  • 50
    Serap Yilmaz, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan Bolelli, Esin Aki Yalcin, Ismail Yalcin. Molecular Docking Studies of Some Novel Bacterial Topoisomerase II Inhibitors, The International Chemical Congress of Pacific Basin Societies 2015 (Pacifichem-2015), Honolulu, Hawaii, USA, 10-HLTH-454: p295, 15-20 December 2015.
  • 49
    Serap Yilmaz, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan Bolelli, Esin Aki Yalcin, Ismail Yalcin. Pharmacophore Generation of Some Novel Benzothiazole Derivatives as Bacterial Topoisomerase II Inhibitors, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, PP2-39: p293, 18-21 October 2015.
  • 48
    Gizem Kunal, Filiz Arioz-Ozdemir, Ozlem Bingol-Ozakpinar, Kayhan Bolelli, Esin Aki-Yalcin, Ismail Yalcin. A New Rapid RP-HPLC Method For Determination Of Novel 2-[4-(4-Ethyl Benzamido)Phenyl]-Benzothiazole, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, PP-74: p195-196, 1-3 October 2015.
  • 47
    Kayhan Bolelli, Hatice Ari, Mustafa Boyukata, Ismail Yalcin, Ozan Unsalan. Micro-Raman, Mid-IR and DFT Studies on 2-[4-(4-Ethylbenzamido)phenyl]benzothiazole, II. International Turkish Congress on Molecular Spectroscopy (TURCMOS 2015), Akdeniz University, Antalya, Turkey, P-136: p215, 13-18 September 2015.
  • 46
    Ozum Ozturk, Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ismail Yalcin. Common Pharmacophore Generation of Some Antitumor Agents, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, PO-1-02: p55, 21-25 June 2015.
  • 45
    Kayhan Bolelli, Tugba Ertan-Bolelli, Ozlem Bingol-Ozakpinar, Filiz Arioz-Ozdemir, Ismail Yalcin, Esin Aki-Yalcin. Cytotoxic Activity of Some Benzazole Derivatives, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, PO-1-07: p60, 21-25 June 2015.
  • 44
    Serap Yilmaz, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan-Bolelli, Dilara Eren, Esin Aki-Yalcin, Ismail Yalcin. Comparison of Pharmacophore Models between Fluoroquinolones and Nonfluoroquinolone Bacterial Type II Topoisomerase Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, PO-2-14: p67, 21-25 June 2015.
  • 43
    Kayhan Bolelli, Tugba Ertan-Bolelli, Ozlem Bingol-Ozakpinar, Filiz Arioz-Ozdemir, Esin Aki-Yalcin, Ismail Yalcin. Anticancer activity of some heterocyclic compounds, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, PP-072: p129, 18-19 May 2015.
  • 42
    Ozum Ozturk, Esin Akı-Yalçın, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz, İsmail Yalçın. Pharmacophore generation of neurokinin-1 receptor antagonists as antitumor agents, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, PP-094: p151, 18-19 May 2015.
  • 41
    Tugba Ertan-Bolelli, Kayhan Bolelli, Yaman Musdal, Bengt Mannervik, Esin Aki-Yalcin, Ismail Yalcin. Molecular modeling studies on human glutathione-S-transferase enzyme, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, PP-119: p176, 18-19 May 2015.
  • 40
    Ilkay Yildiz, Tugba Ertan-Bolelli, Sanaz Ataei, Serap Yilmaz, Esin Karatas, Kayhan Bolelli, Ozum Ozturk, Ismail Yalcin. Molecular Docking and Pharmacophore Analysis on some Topoisomerase I Targetted Antitumor Benzoxazole and Analogues, 9th Drug Design & Medicinal Chemistry, Berlin, Germany, 5-6 May 2015.
  • 39
    Tubanur Ustaömer Dere, Kayhan Bolelli, İlkay Yıldız. Yataklı Tedavi Hizmetlerinde Klinik Eczacının Yeri ve Önemi, Kamu Eczacıları Kongresi, Bilkent Otel, Ankara, Türkiye, 6-7 Mart 2015.
  • 38
    Fatma Zilifdar, Egemen Foto, Omur Bostanci, Sibel Sari, Kayhan Bolelli, Ismail Yalcin, Nuran Diril. Mutagenic Activity of 4 Newly Synthesized Heterocyclic Compounds, 1st International Congress & Workshop of Forensic Toxicology (1st ForeTox 2014), Ankara, Turkey, P14: p71, November 29-30, 2014.
  • 37
    Egemen Foto, Fatma Zilifdar, Sibel Sari, Omur Bostanci, Kayhan Bolelli, Ismail Yalcin, Nuran Diril. Mutagenic Activity of Some Benzothiazole Derivatives, 1st International Congress & Workshop of Forensic Toxicology (1st ForeTox 2014), Ankara, Turkey, P16: p73, November 29-30, 2014.
  • 36
    Kayhan Bolelli, Ismail Yalcin, Tugba Ertan-Bolelli, Serap Yilmaz, Ozum Ozturk, Ilkay Yildiz, Esin Aki-Yalcin. Pharmacophore Identification Analysis on hGST P1-1 Enzyme Inhibitory Active Benzazole Derivatives, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, P-P12: p76, September 23-25, 2014.
  • 35
    Ozum Ozturk, Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ilkay Yildiz, Ismail Yalcin. Common Feature Pharmacophore Generation of Neurokinin-1 Receptor Antagonists, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, P-P110: p103, September 23-25, 2014.
  • 34
    Serap Yilmaz, Tugba Ertan Bolelli, Kayhan Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, Esin Aki Yalcin, Ismail Yalcin. Molecular Docking Studies of AcrB Trimeric Multidrug Efflux Pumps, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, P096: p170, 31 August - 4 September 2014.
  • 33
    Ilkay Yildiz, Tugba Ertan-Bolelli, Serap Yilmaz, Sanaz Ataei, Kayhan Bolelli, Ozum Ozturk, Esin Karatas, Esin Aki-Yalcin, Ismail Yalcin. Molecular Modeling Studies on Some Benzazole Derivatives as Topoisomerase I Poison, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, P147: p221, 31 August - 4 September 2014.
  • 32
    Ismail Yalcin, Tugba Ertan Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki Yalcin. Description of the Binding Site and GSH Conjugation Features of the New Human GST P1-1 Inhibitors, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, P150: p224, 31 August - 4 September 2014.
  • 31
    Unsalan, O.*, Sert, Y., Ari, H., Simão, A., Yilmaz, A., Boyukata, M., Bolukbasi, O., Bolelli, K., Yalcin, I. Micro-Raman, Mid-IR, Far-IR and DFT studies on 2-[4-(4-Fluorobenzamido)phenyl]benzothiazole, 32nd European Congress on Molecular Spectroscopy (EUCMOS 2014), Düsseldorf, Germany, Po2.19: p268, August 24-29, 2014.
  • 30
    J.B. Bhagyasree, Hema Tresa Varghese, C. Yohannan Panicker, Jadu Samuel, Christian Van Alsenoy, Kayhan Bolelli, Ilkay Yildiz, Esin Aki. Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole, 2nd International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, PP-26: p54, 25-28 October 2013.
  • 29
    Kayhan Bolelli, Ismail Yalcin, Tugba Ertan-Bolelli, Serap Yilmaz, Ozum Ozturk, Yaman Musdal, Ilkay Yildiz and Esin Aki-Yalcin. Molecular Docking Studies of Glutathion S-Transferase Inhibitors, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-03: p62, 15-18 October 2013.
  • 28
    Serap Yilmaz, Ismail Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, and Esin Aki-Yalcin. Molecular Docking Studies on AcrB Trimeric Multidrug Efflux Pumps of Escherichia coli, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-04: p63, 15-18 October 2013.
  • 27
    Tugba Ertan-Bolelli, Ilkay Yildiz, Selda Ozgen, Kayhan Bolelli, Serap Yilmaz, Sanaz Ataei, Ozum Ozturk, Esin Aki-Yalcin, and Ismail Yalcin. Molecular Docking Studies on Enoyl-ACP Reductase Enzyme, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-05: p64, 15-18 October 2013.
  • 26
    Kayhan Bolelli, Tuğba Ertan-Bolelli, Yaman Musdal, Serap Yilmaz, Ozum Ozturk, Yasemin Aksoy, Ilkay Yildiz, Esin Aki, Ismail Yalcin. Docking Studies on Glutathione S-Transferase P1-1 Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-03: p66, 8-12 October 2013.
  • 25
    Tugba Ertan-Bolelli, Ilkay Yildiz, Kayhan Bolelli, Serap Yilmaz, Sanaz Ataei, Ozum Ozturk, Selda Ozgen, Esin Aki, Ismail Yalcin. Molecular Docking Studies on Dihydropteroate Synthase Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-09: p72, 8-12 October 2013.
  • 24
    Y. Sheena Mary, K. Raju, Tuğba Ertan Bolelli, Kayhan Bolelli, Ilkay Yıldız, Helena I.S. Nogueira, Carlos M. Granadeiro, Christian Van Alsenoy. FT-IR, FT-Raman, surface enhanced Raman scattering and computational study of 2-[p-fluorobenzyl)-6-nitrobenzoxazole, International Turkish Congress on Molecular Spectroscopy (TURCMOS 2013), Harbiye Cultural Center & Museum, Istanbul, TURKEY, P106: p188-189, September 15-20, 2013.
  • 23
    Unsalan, O., Sert, Y., Ari, H., Simão, A., Yilmaz, A., Boyukata, M., Bolukbasi, O., Bolelli, K., Yalcin, I. Micro-Raman, Mid-IR, Far-IR and DFT studies on 2-[4-(4-Fluorobenzamido)phenyl]benzothiazole, International Turkish Congress on Molecular Spectroscopy (TURCMOS 2013), Harbiye Cultural Center & Museum, Istanbul, TURKEY, P147: p230, September 15-20, 2013.
  • 22
    Sanaz ATAEI, Serap YILMAZ, Ilkay YILDIZ, Tugba ERTAN-BOLELLI, Kayhan BOLELLI, Ozum OZTURK, Esin AKI-YALCIN, Ismail YALCIN. Molecular nDocking Studies of Some Benzazole Derivatives as DNA Topoisomerase I Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT006: p182, 3-5 July 2013.
  • 21
    Ozum OZTURK, Esin AKI-YALCIN, Tugba ERTAN-BOLELLI, Kayhan BOLELLI, Serap YILMAZ, Sanaz ATAEI, Ilkay YILDIZ, Ismail YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT094: p268, 3-5 July 2013.
  • 20
    Serap YILMAZ, Ismail YALCIN, Tugba ERTAN-BOLELLI, Kayhan BOLELLI, Ozum OZTURK, Ilkay YILDIZ, Esin AKI-YALCIN. Molecular Modeling and Docking Studies of AcrB Trimeric Multidrug Efflux Pumps, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P11: p63, 21-23 March 2013.
  • 19
    Ozum OZTURK, Esin AKI-YALÇIN, Tuğba ERTAN-BOLELLİ, Kayhan BOLELLİ, Serap YILMAZ, İlkay YILDIZ, İsmail YALÇIN. Docking Studies of Human Topoisomerase II Enzyme Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P12: p64, 21-23 March 2013.
  • 18
    Kayhan BOLELLI, Ismail YALCIN, Tugba ERTAN-BOLELLI, Serap YILMAZ, Ozum OZTURK, Ilkay YILDIZ, Esin AKI-YALCIN. Docking Studies of Glutathion S-Transferase (GST) Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P13: p65, 21-23 March 2013.
  • 17
    Sibel Sarı*, Şerife Ömür Bostancı, Egemen Foto, Kayhan Bolelli, Nuran Diril. Benzotiyazol türevi bileşiklerin Ames Test Sistemi ile mutajenik potansiyellerinin belirlenmesi, IV. Multidisipliner Kanser Kongresi, Prof. Dr. Mete Cengiz Kültür Merkezi, Bursa, Türkiye, 13-16 Aralık 2012.
  • 16
    Emine Öksüzoğlu, Kayhan Bolelli, Tuğba Ertan-Bolelli, Serap Yılmaz, Nuran Diril. A Study on Mutagenic Effects of Novel Benzoxasole Derivative Compounds by Ames/Salmonella Microsomal Test System, 8. Uluslararası Katılımlı Türk Toksikoloji Derneği Kongresi (8.TTDK), Beldibi-Kemer, Antalya, Turkey, P67: p66, 15-18 Kasım 2012.
  • 15
    Kayhan Bolelli, Serap Yilmaz, Ilkay Yildiz, Esin Aki, Ismail Yalcin. Common Feature Pharmacophore Generation of Bacterial AdeABC Efflux Pump Inhibitors, EuroQSAR Knowledge Enabled Ligand Design, 19th European Symposium on Quantitative Structure-Activity Relationships (19th EuroQSAR), Vienna, Austria, P078: p141, 26-30 August 2012.
  • 14
    Esin Aki, Tugba Taskin, Ismail Yalcin, Yaman Musdal, Yasemin Aksoy, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ilkay Yildiz. Computational Drug Design Studies of Some New GST Inhibitory Active 2-SEsin Aki, Tugba Taskin, Ismail Yalcin, Yaman Musdal, Yasemin Aksoy, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ilkay Yildiz. Computational Drug Design Studies of Some New GST Inhibitory Active 2-Substituted Benzoxazoles and Benzothiazoles, EuroQSAR Knowledge Enabled Ligand Design, 19th European Symposium on Quantitative Structure-Activity Relationships (19th EuroQSAR), Vienna, Austria, P093: p156, 26-30 August 2012.ubstituted Benzoxazoles and Benzothiazoles, 19th European Symposium on Quantitative Structure-Activity Relationships (19th EuroQSAR), Vienna, Austria, P093: p156, 26-30 August 2012.
  • 13
    Kayhan Bolelli, Tugba Ertan-Bolelli, Ozum Ozturk, Ilkay Yildiz Esin Aki, Ismail Yalcin. Docking Studies of Some Fused Heterocyclic Compounds into HIV-1 Reverse Transcriptase Enzyme, EuroQSAR Knowledge Enabled Ligand Design, 19th European Symposium on Quantitative Structure-Activity Relationships (19th EuroQSAR), Vienna, Austria, P095: p158, 26-30 August 2012.
  • 12
    Yasemin Aksoy, Deniz Ceyhan, Yaman Musdal, Esin Akı, Tugba Ertan-Bolelli, Kayhan Bolelli, Ilkay Yildiz, Ismail Yalcin. 2-Substituted Benzazole Derivatives, Suicide Inhibitors For Glutathione S-Transferases and Docking Studies, 7th International Symposium on Health Informatics and Bioinformatics (HIBIT 2012), Perissia Hotel, Urgup, Cappadocia, Nevsehir, Turkey, 19-22 April 2012.
  • 11
    Kayhan Bolelli, Serap Yılmaz, İsmail Yalçın, İlkay Yıldız, Esin Akı. QSAR Analysis of Some 2-Substituted Benzothiazoles as Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus, 1st International Conference on New Trends in Chemometrics and Applications (NTCA-2011), Side, Antalya, Turkey, PP-37: p64, 08-11 October 2011.
  • 10
    Kayhan Bolelli, Tugba Ertan-Bolelli İsmail Yalcin, Esin Akı, İlkay Yıldız. Bazi Yeni 2-[4-(4-Sübstitüebenzamido)fenil] benzotiyazol Türevlerinin 1H-NMR Spektroskopi Çalışmaları, Uluslararası Katılımlı XII. Ulusal Spektroskopi Kongresi (USK-12), Side, Antalya, Türkiye, P-210: p248, 18-22 Mayıs 2011.
  • 9
    İlkay Yıldız, Sanaz Ataei, Serap Yılmaz, Egemen Foto, Tugba Ertan-Bolelli, Kayhan Bolelli, Nuran Diril, Esin Akı-Yalcin, İsmail Yalcin. Three-Dimensional Common-Feature Hypotheses on Benzoxazine Derivatives as Topoisomerase I Inhibitors, The 18th International Conference on Organic Synthesis (ICOS-18), Bergen, Norway, 377: p54, 1-6 August 2010.
  • 8
    Kayhan Bolelli, İsmail Yalçın. Bazı Yeni 2-[4-(4-Sübstitüebenzamido/Fenilasetamido) fenil]benzotiyazol Türevlerinin Sentezi, Yapılarının Aydınlatılması ve Mikrobiyolojik Aktivite Çalışmaları, II. Ulusal Farmasötik Kimya Kongresi (UFKK-2), Mersin, Türkiye, P-11: p22, 13-15 Kasım 2009.
  • 7
    Tugba Ertan-Bolelli, İlkay Yildiz, Kayhan Bolelli, Betül Tekiner-Gulbas, Serap Yilmaz, Özlem Temiz-Arpaci, Esin Aki and Ismail Yalcin. Pharmacophore Analysis on Some Benzoxazoles against Drug-Resistant Escherichia coli, Fifth International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2009), Istanbul, Turkey, PO-41: p108, 4-8 July 2009.
  • 6
    Tugba Ertan-Bolelli, İlkay Yildiz, Kayhan Bolelli, Esin Aki, Ismail Yalcin. Pharmacophore Analysis on Some Benzoxazoles against Drug-Resistant Bacillus subtilis, 45th International Conference on Medicinal Chemistry (RICT-45), University of Orléans, Orléans, France, SL-11: p111, 1-3 July 2009.
  • 5
    Kayhan Bolelli, İsmail Yalcın, Tugba Ertan-Bolelli, İlkay Yıldız, Esin Akı and Fatma Kaynak-Onurdag. Synthesis, Structure Elucidation and Microbiological Activity of Some New 2-[4-(4-SubstitutedPhenylacetamido) phenyl] benzothiazole Derivatives, 45th International Conference on Medicinal Chemistry (RICT-45), University of Orléans, Orléans, France, SL-12: p112, 1-3 July 2009.
  • 4
    Ilkay Yildiz, Tugba Ertan, Kayhan Bolelli, Ozlem Temiz-Arpaci, Ismail Yalcin, Esin Akı-Sener. Molecular Modelling Studies on Some Benzazoles as Eukaryotic DNA Topoisomerase II Inhibitors, 4th Central European Conference Chemistry towards Biology (CTB4), Dobogókő, Hungary, P: p135, 8-11 September 2008.
  • 3
    BOLELLİ, K., YALCIN, I., ERTAN, T., KAYNAK-ONURDAG, F., YILDIZ, I., TEMIZ-ARPACI, I., AKI-SENER, E., ABBASOGLU, U., "Synhtesis, Structure Elucidation and Microbiological Activity of Some New 2-[4-(4-Substitutedbenzamido)phenyl]benzothiazole Derivatives", Abst. P-61, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.
  • 2
    T. Ertan, I. Yıldız, B. Tekiner-Gülbaş, K. Bolelli, O. Temiz-Arpacı, S. Özkan, U. Abbasoğlu. Synthesis and in vitro Antibacterial Activity against Pseudomonas aeruginosa of Some Novel 2-Phenyl Benzoxazoles, 8th International Symposium on Pharmaceutical Sciences (ISOPS-8), Ankara, Turkey, P197: p315, 13-16 June 2006.
  • 1
    ERTAN, T., YILDIZ, I., BOLELLI, K., TEMİZ-ARPACI, O., TEKİNER-GÜLBAŞ, B., AKI-ŞENER, E., YALÇIN, I., ABBASOGLU; U., “Synthesis and antibacterial activity of some 4-substituted-N-(2-hydroxy-5(or 6)-nitrophenyl)benzamide derivatives” International Symposium on Medicinal Chemistry Research and Development Kusadasi, Turkey, Abstract P81, September 28-October 1, 2005,.

Premios Póster

  • 1
    Egemen Foto*, Fatma Zilifdar, Sibel Sari, Omur Bostanci, Kayhan Bolelli, Ismail Yalcin, Nuran Diril. Mutagenic Activity of Some Benzothiazole Derivatives, 1st International Congress & Workshop of Forensic Toxicology (1st ForeTox 2014), Ankara, Turkey, P16: p73, November 29-30, 2014. - 2nd POSTER AWARD (ULUSLARARASI ADLİ TOKSIKOLOJİ KONGRE VE ÇALIŞTAYI - Poster 2.’lik Ödülü) [texto íntegro]

Artículos del Congreso

  • 4
    Mustafa Lawar, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli, “QSAR Study on Thiosemicarbazone Derivatives as Ribonucleotide Reductase Inhibitors”, Electronic Letters on Science&Engineering, 13(2) Special Issue: p37-38, (2017). [texto íntegro]
  • 3
    Fatma Zilifdar, Egemen Foto, Omur Bostanci, Sibel Sari, Kayhan Bolelli, Ismail Yalcin, Nuran Diril, “Mutagenic Activity of 4 Newly Synthesized Heterocyclic Compounds”, The Turkish Journal of Occupational / Environmental Medicine and Safety (TURJOEM), 1(1), Suppl. 1: 14, (2015). [texto íntegro]
  • 2
    Egemen Foto, Fatma Zilifdar, Sibel Sari, Omur Bostanci, Kayhan Bolelli, Ismail Yalcin, Nuran Diril, “Mutagenic Activity of Some Benzothiazole Derivatives”, The Turkish Journal of Occupational / Environmental Medicine and Safety (TURJOEM), 1(1), Suppl. 1: 16, (2015). [texto íntegro]
  • 1
    AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships", Med. Chem. Res., 19(Suppl.), S6, (2010). DOI 10.1007/s00044-010-9296-3 [texto íntegro]

Comunicaciones Breves

  • 2
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Esin Aki-Yalcin, Ufuk Over-Hasdemir, “Binding site description of 2-substituted benzothiazoles as potential RND efflux pump inhibitors”, Macedonian pharmaceutical bulletin, 62 (suppl): 543-544, (2016). [texto íntegro]
  • 1
    Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Ismail Yalcin, “Docking studies of neurokinin-1 receptor antagonists as an anticancer target”, Macedonian pharmaceutical bulletin, 62 (suppl): 553-554, (2016). [texto íntegro]